Universität zu Köln

Nitz, U., Gluz, O., Krepe, H., Liedtke, B., Aktas, B., Henschen, S., Pollmanns, A., Krabisch, P., Zuna, I., Shak, S., Thomsseen, C. and Harbeck, N. (2011). First Interim Toxicity Analysis of the Randomized Phase III WSG Plan B Trial Comparing 4xEC-4xDoc Versus 6xTC in Breast Cancer Patients with HER2 Negative Breast Cancer (BC). Cancer Res., 71. PHILADELPHIA: AMER ASSOC CANCER RESEARCH. ISSN 1538-7445

Full text not available from this repository.

Item Type:	Journal Article
Creators:	Creators Email ORCID ORCID Put Code Nitz, U. UNSPECIFIED UNSPECIFIED UNSPECIFIED Gluz, O. UNSPECIFIED UNSPECIFIED UNSPECIFIED Krepe, H. UNSPECIFIED UNSPECIFIED UNSPECIFIED Liedtke, B. UNSPECIFIED UNSPECIFIED UNSPECIFIED Aktas, B. UNSPECIFIED UNSPECIFIED UNSPECIFIED Henschen, S. UNSPECIFIED UNSPECIFIED UNSPECIFIED Pollmanns, A. UNSPECIFIED UNSPECIFIED UNSPECIFIED Krabisch, P. UNSPECIFIED UNSPECIFIED UNSPECIFIED Zuna, I. UNSPECIFIED UNSPECIFIED UNSPECIFIED Shak, S. UNSPECIFIED UNSPECIFIED UNSPECIFIED Thomsseen, C. UNSPECIFIED UNSPECIFIED UNSPECIFIED Harbeck, N. UNSPECIFIED UNSPECIFIED UNSPECIFIED
URN:	urn:nbn:de:hbz:38-483430
DOI:	10.1158/0008-5472.SABCS11-P5-18-03
Journal or Publication Title:	Cancer Res.
Volume:	71
Date:	2011
Publisher:	AMER ASSOC CANCER RESEARCH
Place of Publication:	PHILADELPHIA
ISSN:	1538-7445
Language:	English
Faculty:	Unspecified
Divisions:	Unspecified
Subjects:	no entry
Uncontrolled Keywords:	Keywords Language Oncology Multiple languages
URI:	http://kups.ub.uni-koeln.de/id/eprint/48343